Literature DB >> 7745430

Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation.

T J Montine1, D B Farris, D G Graham.   

Abstract

Brainstem Lewy bodies (LB) are neuronal inclusions that are closely related to Parkinson's disease (PD). The filamentous component of LB from patients with PD contains biochemically altered neurofilaments (NF). Herein we have tested the hypothesis that the oxidized products of catechols may covalently crosslink NF. Neurofilaments were incubated in the presence of oxidized L-dopa, dopamine, or dopac and then analyzed by SDS-PAGE and protein staining or immunoblotting with monoclonal antibodies specific for neurofilament subunit proteins. Oxidized catechols yielded the same pattern of NF protein crosslinking as known covalent crosslinking agents. Coincubation of NF and catechols with N alpha-acetyl-L-lysine (NAL) produced strong reactivity on immunoblots probed with a polyclonal antiserum specific for NAL crosslinked to protein (antiserum 1400/3). Crosslinking of NAL to model proteins by oxidized dopac was followed by antibody capture assays using antiserum 1400/3. Increasing immunoreactivity was observed for 0.01 to 1.0 mM dopac and was augmented by Cu2+, Fe2+, Fe3+, Mn2+, or Mn3+ up to 0.1 mM. These results show that the products of catechol oxidation can covalently crosslink neurofilaments, that the crosslinking mechanism can involve lysine, and that copper, iron, and manganese ions can accelerate catechol-mediated protein crosslinking.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745430     DOI: 10.1097/00005072-199505000-00004

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  12 in total

1.  Reactivity of peptidyl-tyrosine to hydroxylation and cross-linking.

Authors:  L A Burzio; J H Waite
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  Chemistry of periodate-mediated cross-linking of 3,4-dihydroxylphenylalanine-containing molecules to proteins.

Authors:  Bo Liu; Lyle Burdine; Thomas Kodadek
Journal:  J Am Chem Soc       Date:  2006-11-29       Impact factor: 15.419

3.  Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.

Authors:  K S Montine; S J Olson; V Amarnath; W O Whetsell; D G Graham; T J Montine
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 4.  Are dopamine receptor agonists neuroprotective in Parkinson's disease?

Authors:  W D Le; J Jankovic
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Dopamine thioethers: formation in brain and neurotoxicity.

Authors:  Kathleen S. Montine; Kathrin R. Sidell; Jing Zhang; Thomas J. Montine
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

6.  Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.

Authors:  Se Joon Choi; Anne Panhelainen; Yvonne Schmitz; Kristin E Larsen; Ellen Kanter; Min Wu; David Sulzer; Eugene V Mosharov
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

7.  Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis.

Authors:  Walter E Zink; Eric Anderson; Jeffrey Boyle; Lynette Hock; Jorge Rodriguez-Sierra; Huangui Xiong; Howard E Gendelman; Yuri Persidsky
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

8.  Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease.

Authors:  W Le; D Rowe; W Xie; I Ortiz; Y He; S H Appel
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

9.  Intraneuronal dopamine-quinone synthesis: a review.

Authors:  D Sulzer; L Zecca
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

10.  Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells.

Authors:  Victor S Van Laar; Amanda J Mishizen; Michael Cascio; Teresa G Hastings
Journal:  Neurobiol Dis       Date:  2009-03-28       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.